NCT07477496

Brief Summary

Perianal fistulas are a chronic anorectal condition associated with significant morbidity, including pain, persistent discharge, infection, and impaired continence, all of which can substantially affect patients' quality of life. Surgical management aims to eradicate the fistulous tract while preserving anal sphincter function and continence. Despite numerous available surgical techniques, high-quality comparative evidence regarding optimal management remains limited. This prospective observational study aims to evaluate clinical outcomes, functional outcomes, and patient-reported quality of life following surgical treatment of perianal fistulas. The study will collect both clinician-reported and patient-reported outcomes over a 12-month follow-up period. Outcomes of interest include fistula healing, recurrence, postoperative complications, continence status, symptom burden, and health-related quality of life. The findings are expected to provide real-world data that may inform clinical decision-making and contribute to improved patient-centered care.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
42mo left

Started Jan 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Jan 2026Jan 2030

Study Start

First participant enrolled

January 1, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 11, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 17, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2030

Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

2 years

First QC Date

March 11, 2026

Last Update Submit

March 17, 2026

Conditions

Keywords

perianalfistulaanalPROMspatient-reported outcomesquality of life

Outcome Measures

Primary Outcomes (2)

  • Proportion of patients with complete fistula healing (clinical examination)

    No clinically detectable perianal discharge, no signs of infection or inflammation, and no palpable/visible fistulous tract on physical examination.

    1, 3, 6, 12 and 24 months

  • Quality of Life (QoL)

    Anal Fistula Quality of Life (AF-QoL) questionnaire (0 = worst QoL, 100 = best QoL; higher scores indicate better health-related QoL)

    1, 3, 6, 12 and 24 months

Secondary Outcomes (7)

  • Recurrence rate

    12 and 24 months

  • Incontinence symptoms

    1, 3, 6, 12 and 24 months

  • Complications, Re-interventions, Readmission, Mortality

    1, 3, 6, 12 and 24 months

  • Clavien-Dindo classification of complications

    1, 3, 6, 12 and 24 months

  • Patient satisfaction

    1, 3, 6, 12 and 24 months

  • +2 more secondary outcomes

Study Arms (1)

Perianal-Fistula Surgical Cohort

Adults (≥ 18 y) undergoing any elective surgical repair for a primary or recurrent perianal fistula (simple or complex) in our center. All participants are followed prospectively for a minimum of 12 months with standardized clinician- and patient-reported outcome assessments.

Procedure: Perianal fistula surgical repair

Interventions

Patients undergo the operative procedure that their treating colorectal surgeon selects as routine clinical care for a primary or recurrent perianal fistula. The operative approach may be a sphincter-dividing technique (e.g., fistulotomy or fistulectomy) or a sphincter-preserving technique (e.g., ligation of the intersphincteric fistula tract \[LIFT\], mucosal advancement flap, laser fistula treatment, fistula plug, autologous biologic product injection, or seton placement). No investigational devices or experimental protocols are used; the study records the specific technique, intra-operative details, and any adjunctive measures (draining seton, pre-operative imaging, antibiotics, etc.) to allow comparison of real-world outcomes across all accepted surgical modalities for perianal fistulas.

Perianal-Fistula Surgical Cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will enroll adult patients with cryptoglandular perianal fistulas who are scheduled for elective surgical repair. Participants will be free of inflammatory bowel disease and major anorectal resections, and they will be able to provide informed consent, complete validated patient-reported outcome measures, and comply with the scheduled 12-month follow-up protocol.

You may qualify if:

  • Age ≥ 18 years.
  • Clinically and/or radiologically confirmed perianal fistula (primary or recurrent).
  • Planned definitive surgical treatment (any sphincter-dividing or sphincter-preserving technique).
  • Ability to understand and complete study questionnaires.
  • Commitment to attend follow-up visits at 1, 3, 6, and 12 months (or to complete remote assessments).
  • Signed written informed consent.

You may not qualify if:

  • Diagnosed inflammatory bowel disease (Crohn's disease or ulcerative colitis).
  • Active perianal sepsis requiring emergency drainage after enrolment and before definitive surgery.
  • Prior abdominoperineal resection or permanent colostomy.
  • Pregnancy or planned pregnancy during the 12-month follow-up.
  • Severe uncontrolled systemic disease (e.g., decompensated heart failure, end-stage renal disease, uncontrolled diabetes).
  • Cognitive impairment or psychiatric disorder precluding reliable consent or questionnaire completion.
  • Lack of reliable contact information or inability to attend at least one scheduled follow-up visit.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ippokrateio Hospital

Athens, Greece

RECRUITING

MeSH Terms

Conditions

Rectal FistulaFistula

Condition Hierarchy (Ancestors)

Intestinal FistulaDigestive System FistulaDigestive System DiseasesIntestinal DiseasesGastrointestinal DiseasesRectal DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Central Study Contacts

George Theodoropoulos

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
24 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

March 11, 2026

First Posted

March 17, 2026

Study Start

January 1, 2026

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2030

Last Updated

March 19, 2026

Record last verified: 2026-03

Locations